An Brebels SRL
An Brebels reported total assets of 313,168 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
The score of An Brebels shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets +275 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
An Brebels's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
An Brebels's financial analysis
- Solvency30.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of An Brebels
An Brebels's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0729.909.162
- VAT number
- BE0729909162
- Peppol
- Registered · 0208:0729909162 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Jul 2019
- Registered office
- 3660 Oudsbergen
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
An Brebels (SRL) has been based in Oudsbergen since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 6,775 € and equity of 94,772 €; its revenue is not published. Its solvency stands at 30.3%, below the median of its sector (44.2%).
Companies similar to An Brebels
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Tanghe - Vanneste Retail sale of pharmaceutical products Pajottegem · balance sheet 318,191 €
- Pharmacie Godin Retail sale of pharmaceutical products Auderghem · balance sheet 314,922 €
- Leeman Apotheek Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 310,011 €
- Somapi Retail sale of pharmaceutical products Liège · balance sheet 317,064 €
- Vision 2017 Retail sale of pharmaceutical products Schaerbeek · balance sheet 318,760 €
- Apoteek Windey Retail sale of pharmaceutical products Hamme (Vl.) · balance sheet 306,023 €
- Sanaspe Retail sale of pharmaceutical products Anderlecht · balance sheet 305,664 €
- Milan Apotica Retail sale of pharmaceutical products Waterloo · balance sheet 321,144 €
Frequently asked questions about An Brebels
What is the revenue of An Brebels?
An Brebels files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of An Brebels?
In Belgium, the VAT number is the company number prefixed with BE: BE0729909162 for An Brebels, if the company is VAT-registered. Its company number (CBE) is 0729.909.162.
Where is the registered office of An Brebels?
According to the CBE register, the registered office of An Brebels is in 3660 Oudsbergen.
What is the equity of An Brebels?
At the close of the 2025 financial year, the equity of An Brebels amounts to 94,772 €, a solvency of 30.3% of total assets.
Who manages An Brebels?
The register lists 1 active mandates at An Brebels. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of An Brebels
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →